Search Follow us

Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Sean Conroy

Sean Conroy
Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Alice Nettleton

Alice Nettleton
Healthcare Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Andy Smith

Andy Smith

Briana Warschun

Briana Warschun
Associate Healthcare Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

BioLargo Brighter
Herantis Pharma Acacia Pharma
Destiny Pharma BioPorto Diagnostics

Recent QuickViews

Smith & Nephew

Turning over that new leaf

Pharmaceutical & healthcare | published 28/09/2018
Medicure

Building a cardiovascular franchise

Pharmaceutical & healthcare | published 03/07/2018
Antibe Therapeutics

Working towards a GI-safe NSAID drug

Pharmaceutical & healthcare | published 14/06/2018
Avivagen

Antibiotic-free alternative for animal feed

Pharmaceutical & healthcare | published 12/06/2018

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Newron Pharmaceuticals

Next up - R&D day

Update | Pharmaceutical & healthcare | 11/10/2018

Newron continued to made steady progress in H118. A fuller debrief of pipeline assets including sarizotan (Rett syndrome) and Evenamide (schizophrenia)…

Acacia Pharma

FDA issues CRL for BARHEMSYS

Update | Pharmaceutical & healthcare | 10/10/2018

Acacia Pharma has received a Complete Response Letter (CRL) from the FDA for lead asset BARHEMSYS (repurposed amisulpride) for the management of post-operative…

BioPorto Diagnostics

NGAL test hits a snag at FDA

Update | Pharmaceutical & healthcare | 09/10/2018

BioPorto announced on 3 October 2018 that it had received feedback from the FDA on its outstanding 510(k) application for The NGAL Test for risk use with…

Quantum Genomics

NEW-HOPE data to be presented at AHA

Update | Pharmaceutical & healthcare | 09/10/2018

Quantum Genomics has announced that the results of its Phase IIb NEW-HOPE study will be presented in a late-breaking presentation at the American Heart…

Oncology Venture

LiPlaCis focused Phase II interim data

Update | Pharmaceutical & healthcare | 09/10/2018

In mid-September, Oncology Venture (OV) provided an update on its focused Phase II study investigating LiPlaCis in heavily pre-treated metastatic breast…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies